Skip to main content
๐ŸงฌPeptide Protocol Wiki

PP405: Community Protocols & Reports

Aggregated community experiences, protocols, and stacking patterns

Anecdotal Reports0

Community-Sourced Information

The protocols and reports on this page are gathered from online communities and forums. They represent anecdotal experiences, not clinical evidence. Individual results vary significantly. This information is not medical advice and should not replace consultation with a qualified healthcare provider. Always verify dosing and safety information with peer-reviewed research before making any decisions.

For peer-reviewed dosing protocols, see the clinical dosing guide.

Browse community protocols for all 130 peptides โ†’

โœ“Reviewed byEditorial Team
๐Ÿ“…Updated February 16, 2026
Unverified

๐Ÿ“ŒTL;DR

  • โ€ขCommunity protocols detailed below
  • โ€ขEvidence level: Anecdotal Reports
  • โ€ขSee community reports below
  • โ€ขStacking patterns detailed below

Sources

Community Evidence Overview#

This page documents the community evidence landscape for PP405. This is not clinical evidence and should not be used as medical guidance.

PP405 has no community self-experimenter data. It is an investigational topical compound in Phase 2 clinical trials for hair loss.

Why There Is No Community Data#

Pre-Market Investigational Status#

PP405 is in Phase 2 clinical development by Pelage Pharmaceuticals, with Phase 3 trials planned for 2026. The compound is only available to patients enrolled in clinical trials.

Proprietary Formulation#

PP405's specific chemical identity and formulation have not been publicly disclosed, making independent synthesis or compounding impossible. The topical delivery system is also proprietary.

Hair Loss Community Interest#

While there is no self-experimenter data for PP405 itself, the hair loss community (particularly r/tressless on Reddit) closely follows the treatment pipeline. PP405's Phase 2a results showing 31% of men with advanced hair loss achieving greater than 20% increase in hair density at 8 weeks (vs 0% placebo) have generated notable interest, particularly because:

  • It works through a novel non-hormonal mechanism
  • It is applied topically with no systemic absorption detected
  • It may work in both men and women
  • Rapid onset (8 weeks) compared to months for existing treatments
  • It targets dormant follicle stem cells, potentially addressing a different aspect of hair loss than current treatments

Subscribe to see vendor options

Free access to verified vendor scores, pricing, and suppliers.

150+ peptide profiles ยท 30+ comparisons ยท 18 research tools

Already subscribed?

Frequently Asked Questions About PP405

Explore Further

โš ๏ธ

Medical Disclaimer

This website is for educational and informational purposes only. The information provided is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before using any peptide or supplement.